See also
- C-suite
- Chief experimental officer (CEO)
- Chief innovation officer (CINO)
- Chief technology officer (CTO)
A chief scientific officer (CSO) is a position at the head of scientific research operations at organizations or companies performing significant scientific research projects.
A CSO is typically responsible for envisioning and developing research capabilities (human, methodological, and technological) for developing evidence of the validity and utility of research products, and for communicating with the scientific and customer communities concerning capabilities and scientific product offerings.
In some organizations, the same person may hold this title along with that of chief technology officer (CTO). Alternatively, a company could have one or the other, or both occupied by separate people. Often, CSOs exist in heavily research-oriented companies; while CTOs exist in product development focused companies. The typical category of research and development that exists in many science and technology companies can be led by either post, depending upon which area is the organization's primary focus.
A CSO almost always has a pure science background and an advanced degree, whereas a CTO often has a background in engineering or business development.
Some academic research organizations, such as the Fox Chase Cancer Center, [1] Dana-Farber Cancer Institute, [2] and the San Diego Supercomputer Center have adopted a similar title of CSO. [3] Typically, their role is to evaluate and set scientific priorities and coordinate the administrative structure that supports scientists. A CSO commonly has a scientific or academic background, yet they may or may not be practicing scientists or academics.
In the National Health Service, the CSO is the head of profession for the 53,000 healthcare scientists working in the organization and its associated bodies. The CSO is one of six NHS professional officers (including the chief medical officer and the chief nursing officer) who are employed within NHS England. These roles lead their own professional groups as well as providing expert knowledge about their specific disciplines to the NHS and wider health and care system. [4]
The CSO provides professional leadership and expert clinical advice across the health system, as well as working alongside senior clinical leaders within NHS England and the broader commissioning system. [5] The CSO is also responsible for delivering the government's strategy for a modernised healthcare science workforce, Modernising Scientific Careers.
Professor Dame Sue Hill has been the CSO since October 2002 first within the department of health and subsequently NHS England. [6] The role was strengthened in March 2013 with the appointment of a deputy CSO. [7]
The Public Health Agency of Canada is home to a CSO. As of May 2020, the PHAC CSO was named Pascal Michel. [8]
The Canadian Food Inspection Agency is home to a Chief Science Operating Officer.
The Department of Health and Social Care (DHSC) is the UK government department responsible for government policy on health and adult social care matters in England, along with a few elements of the same matters which are not otherwise devolved to the Scottish Government, Welsh Government or Northern Ireland Executive. It oversees the English National Health Service (NHS). The department is led by the secretary of state for health and social care with three ministers of state and three parliamentary under-secretaries of state.
A chief technology officer (CTO), also known as a chief technical officer or chief technologist, is an executive-level position in a company or other entity whose occupation is focused on the scientific and technological issues within an organization.
Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana–Farber is the founding member of Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
The Pritzker School of Medicine is the M.D.-granting unit of the Biological Sciences Division of the University of Chicago. It is located on the university's main campus in the historic Hyde Park neighborhood of Chicago and matriculated its first class in 1927. The medical school offers a full-time Doctor of Medicine degree program, joint degree programs, graduate medical education, and continuing medical education.
Arthur D. Levinson is an American businessman and is the current chairman of Apple Inc. (2011–present) and CEO of Calico. He is the former chief executive officer (1995–2009) and chairman (1999–2014) of Genentech.
UCLPartners is an academic health science centre located in London, England. It is the largest academic health science centre in the world, treats more than 1.5 million patients each year, has a combined annual turnover of around £2 billion and includes around 3,500 scientists, senior researchers and consultants.
Professor David James Kerr is a British cancer researcher. His primary area of research is treatment and management of colorectal cancer.
Dame Sally Claire Davies is a British physician and academic administrator who served as the Chief Medical Officer from 2010 to 2019 and as the Chief Scientific Adviser at the Department of Health from 2004 to 2016 and worked as a clinician specialising in the treatment of diseases of the blood and bone marrow. She was appointed Master of Trinity College, Cambridge, on 8 February 2019, effective from 8 October 2019. She is one of the founders of the National Institute for Health and Care Research (NIHR).
The Chief Scientific Officer in England is the head of profession for the 53,000 healthcare scientists working in the National Health Service and its associated bodies.
Dame Susan Lesley Hill has been the Chief Scientific Officer for England since October 2002.
Modernising Scientific Careers (MSC) is a UK-wide government initiative to address the training and education needs of the whole healthcare science workforce in the National Health Service (NHS). The initiative won a Healthcare Innovation Award in 2013. Its stated aims are to introduce flexibility, sustainability and modern career pathways for the healthcare science workforce to meet future needs of the NHS.
John Quackenbush is an American computational biologist and genome scientist. He is a professor of biostatistics and computational biology and a professor of cancer biology at the Dana-Farber Cancer Institute (DFCI), as well as the director of its Center for Cancer Computational Biology (CCCB). Quackenbush also holds an appointment as a professor of computational biology and bioinformatics in the Department of Biostatistics at the Harvard School of Public Health (HSPH).
Biomedical sciences are a set of sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology that are of use in healthcare or public health. Such disciplines as medical microbiology, clinical virology, clinical epidemiology, genetic epidemiology, and biomedical engineering are medical sciences. In explaining physiological mechanisms operating in pathological processes, however, pathophysiology can be regarded as basic science.
Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana-Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.
Stephen Kevin Smith is an academic and health executive who led the creation of the United Kingdom's first Academic Health Science Centre at Imperial College London.
The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new directions. The Szent-Györgyi Prize honors researchers whose discoveries have made possible new approaches to preventing, diagnosing and/or treating cancer. The Prize recipient is honored at a formal dinner and award ceremony and receives a $25,000 cash prize. In addition, the recipient leads the next "Szent-Györgyi Prize Committee" as honorary chairman.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and physician-in-chief of Smilow Cancer Network, effective February 1, 2022. From 1997-2021, he was the Chief of the Breast Oncology Program at Dana-Farber Cancer Institute in Boston, Massachusetts. Beginning in 2013, he held a range of institutional roles at Dana-Farber, most recently as Chief of Clinical Development. He has been the Thompson Chair in Breast Cancer Research and a Professor of Medicine at Harvard Medical School. He is currently the president-elect of the American Society of Clinical Oncology. His career has been focused on breast cancer treatment and research.
Edward J. Benz Jr. is the former president of Dana-Farber Cancer Institute in Boston, Massachusetts., and the Richard and Susan Smith Professor of Medicine as well as a professor of genetics at Harvard Medical School.
Müge Çevik is a physician who is an infectious diseases researcher and science communicator at the University of St Andrews. Her research considers HIV, viral hepatitis, emerging infections and tropical infections in developing countries. During the COVID-19 pandemic, Çevik was an advisor to the Chief Medical Officer of Scotland and the World Health Organization, and is a member of New and Emerging Respiratory Virus Threats Advisory Group - an expert committee of the UK Department of Health advising Scientific Advisory Group for Emergencies.
{{cite web}}: CS1 maint: bot: original URL status unknown (link)